Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MaxiTears Contacts PF

K-Number: K182984 · 2019-07-24

ApplicantOmnivision AG
Decision Date2019-07-24
Product CodeMRC
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

MaxiTears Contacts PF is the device name listed in this FDA 510(k) record. The listed applicant is Omnivision AG. It received FDA 510(k) clearance on 2019-07-24 under 510(k) number K182984. The device is classified under product code MRC. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MaxiTears Contacts PF?

MaxiTears Contacts PF is a medical device that received FDA 510(k) clearance on 2019-07-24. The listed applicant is Omnivision AG. The 510(k) number is K182984.

When did MaxiTears Contacts PF receive FDA 510(k) clearance?

MaxiTears Contacts PF received FDA 510(k) clearance on 2019-07-24, under 510(k) number K182984.

Who is the listed applicant for MaxiTears Contacts PF?

The FDA 510(k) record lists Omnivision AG as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MaxiTears Contacts PF?

The FDA product code for MaxiTears Contacts PF is MRC.

Related Devices (Code: MRC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.